RIM
IONS icon

Rainier Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Rainier Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.16M Sell
23,050
-40,390
-64% -$2.21M 0.49% 73
2017
Q3 		$3.22M Sell
63,440
-13,490
-18% -$707K 0.76% 56
2017
Q2 		$3.91M Sell
76,930
-31,110
-29% -$1.45M 0.78% 47
2017
Q1 		$4.34M Buy
108,040
+7,850
+8% +$353K 0.47% 99
2016
Q4 		$4.79M Sell
100,190
-34,260
-25% -$1.36M 0.47% 96
2016
Q3 		$4.93M Sell
134,450
-20,040
-13% -$627K 0.32% 127
2016
Q2 		$3.6M Sell
154,490
-6,420
-4% -$207K 0.17% 158
2016
Q1 		$6.52M Buy
160,910
+33,880
+27% +$1.38M 0.29% 130
2015
Q4 		$7.87M Sell
127,030
-79,910
-39% -$4.31M 0.31% 123
2015
Q3 		$8.37M Buy
206,940
+48,470
+31% +$2.51M 0.31% 135
2015
Q2 		$9.12M Buy
158,470
+36,260
+30% +$2.31M 0.29% 142
2015
Q1 		$7.78M Sell
122,210
-92,060
-43% -$6.25M 0.16% 165
2014
Q4 		$13.2M Sell
214,270
-149,870
-41% -$7.4M 0.24% 138
2014
Q3 		$14.1M Sell
364,140
-12,590
-3% -$446K 0.24% 142
2014
Q2 		$13M Buy
376,730
+64,890
+21% +$2.04M 0.2% 149
2014
Q1 		$13.5M Sell
311,840
-213,870
-41% -$10.4M 0.16% 160
2013
Q4 		$20.9M Buy
525,710
+504,870
+2,423% +$18M 0.22% 139
2013
Q3 		$782K Buy
+20,840
New +$623K 0.01% 201

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Rainier Investment Management's IONS Position: Q4 2017 in Review

Rainier Investment Management reduced its Ionis Pharmaceuticals (IONS) stake by 64% in Q4 2017, selling an estimated $2.21M and leaving 23,050 shares worth $1.16M. The position accounts for 0.49% of the portfolio, ranked #73.

Rainier Investment Management first reported a position in IONS in Q3 2013 and has held it in 18 quarters since. The position peaked at $20.9M in Q4 2013. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

  • Rainier Investment Management held 23,050 shares of Ionis Pharmaceuticals worth $1.16M as of Q4 2017.
  • Rainier Investment Management sold 40,390 Ionis Pharmaceuticals shares in Q4 2017, an estimated $2.21M.
  • Ionis Pharmaceuticals made up 0.49% of Rainier Investment Management's portfolio in Q4 2017, its #73 holding.
  • Rainier Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 18 quarters since.
  • Rainier Investment Management's Ionis Pharmaceuticals position peaked at $20.9M in Q4 2013.
  • 316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on Rainier Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.